Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Copy number loss in SFMBT1 is common among Finnish and Norwegian patients with iNPH.

Korhonen VE, Helisalmi S, Jokinen A, Jokinen I, Lehtola JM, Oinas M, Lönnrot K, Avellan C, Kotkansalo A, Frantzen J, Rinne J, Ronkainen A, Kauppinen M, Junkkari A, Hiltunen M, Soininen H, Kurki M, Jääskeläinen JE, Koivisto AM, Sato H, Kato T, Remes AM, Eide PK, Leinonen V.

Neurol Genet. 2018 Dec 3;4(6):e291. doi: 10.1212/NXG.0000000000000291. eCollection 2018 Dec.

2.

Completeness-optimized basis sets: application to ground-state electron momentum densities.

Lehtola J, Manninen P, Hakala M, Hämäläinen K.

J Chem Phys. 2012 Sep 14;137(10):104105.

PMID:
22979848
3.

ERKALE-A flexible program package for X-ray properties of atoms and molecules.

Lehtola J, Hakala M, Sakko A, Hämäläinen K.

J Comput Chem. 2012 Jul 5;33(18):1572-85. doi: 10.1002/jcc.22987. Epub 2012 Apr 24.

PMID:
22528614
4.

Cytokine gene polymorphism in microscopic colitis association with the IL-6-174 GG genotype.

Koskela RM, Karttunen TJ, Niemelä SE, Lehtola JK, Bloigu RS, Karttunen RA.

Eur J Gastroenterol Hepatol. 2011 Jul;23(7):607-13. doi: 10.1097/MEG.0b013e328346f5be.

PMID:
21527852
5.

Gastroduodenal mucosa in microscopic colitis.

Koskela RM, Niemelä SE, Lehtola JK, Bloigu RS, Karttunen TJ.

Scand J Gastroenterol. 2011 May;46(5):567-76. doi: 10.3109/00365521.2011.551889. Epub 2011 Feb 3.

PMID:
21291294
6.

Calculation of isotropic Compton profiles with Gaussian basis sets.

Lehtola J, Hakala M, Vaara J, Hämäläinen K.

Phys Chem Chem Phys. 2011 Apr 7;13(13):5630-41. doi: 10.1039/c0cp02269a. Epub 2011 Jan 31.

PMID:
21283842
7.

Universal signature of hydrogen bonding in the oxygen K-edge spectrum of alcohols.

Pylkkänen T, Lehtola J, Hakala M, Sakko A, Monaco G, Huotari S, Hämäläinen K.

J Phys Chem B. 2010 Oct 21;114(41):13076-83. doi: 10.1021/jp106479a.

PMID:
20873748
8.

Structure of liquid linear alcohols.

Lehtola J, Hakala M, Hämäläinen K.

J Phys Chem B. 2010 May 20;114(19):6426-36. doi: 10.1021/jp909894y.

PMID:
20415467
9.

[Update on current care guidelines. Safe use of non-steroidal anti-inflammatory drugs].

Karvonen AL, Hakala M, Helin-Salmivaara A, Kankaanranta H, Kivilaakso E, Kunnamo I, Lehtola J, Martio J.

Duodecim. 2009;125(5):563-4. Finnish.

PMID:
19385345
10.

Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis.

Koskela RM, Karttunen TJ, Niemelä SE, Lehtola JK, Ilonen J, Karttunen RA.

Eur J Gastroenterol Hepatol. 2008 Apr;20(4):276-82. doi: 10.1097/MEG.0b013e3282f2468d.

PMID:
18334870
11.

Clinical significance and outcome of gastric mucosal erosions: a long-term follow-up study.

Toljamo KT, Niemelä SE, Karttunen TJ, Karvonen AL, Lehtola JK.

Dig Dis Sci. 2006 Mar;51(3):543-7.

PMID:
16614965
12.

[Update on current care guidelines. Celiac disease].

Collin P, Julkunen R, Lehtola J, Kaukinen K, Mäki M, Rasmussen M, Reunala T, Savilahti E, Uusitupa M, Vuoristo M, Vuorio A.

Duodecim. 2005;121(24):2705-7. Review. Finnish. No abstract available.

PMID:
16454251
13.

Toxic acute hepatitis and hepatic fibrosis after consumption of chaparral tablets.

Kauma H, Koskela R, Mäkisalo H, Autio-Harmainen H, Lehtola J, Höckerstedt K.

Scand J Gastroenterol. 2004 Nov;39(11):1168-71.

PMID:
15545179
14.

Clinical characteristics of collagenous and lymphocytic colitis.

Koskela RM, Niemelä SE, Karttunen TJ, Lehtola JK.

Scand J Gastroenterol. 2004 Sep;39(9):837-45.

PMID:
15513381
15.

Epithelial cell proliferation and glandular atrophy in lymphocytic gastritis: effect of H pylori treatment.

Mäkinen JM, Niemelä S, Kerola T, Lehtola J, Karttunen TJ.

World J Gastroenterol. 2003 Dec;9(12):2706-10.

16.

Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction.

Heikius B, Niemelä O, Niemelä S, Karttunen TJ, Lehtola J.

Hepatogastroenterology. 2002 Mar-Apr;49(44):404-11.

PMID:
11995461
17.

The role of Herpes simplex and Helicobacter pylori infection in the etiology of persistent or recurrent gastric erosions: a follow-up study.

Toljamo KT, Niemelä SE, Karttunen TJ, Karttunen RA, Karvonen AL, Piiparinen H, Lehtola JK.

Dig Dis Sci. 2002 Apr;47(4):818-22.

PMID:
11991616
18.

Apolipoprotein E and colon cancer. Expression in normal and malignant human intestine and effect on cultured human colonic adenocarcinoma cells.

Niemi M, Hakkinen T, Karttunen TJ, Eskelinen S, Kervinen K, Savolainen MJ, Lehtola J, Makela J, Yla-Herttuala S, Kesaniemi YA.

Eur J Intern Med. 2002 Feb;13(1):37-43.

PMID:
11836081
19.

Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor?

Väre PO, Heikius B, Silvennoinen JA, Karttunen R, Niemelä SE, Lehtola JK, Karttunen TJ.

Scand J Gastroenterol. 2001 Dec;36(12):1295-300.

PMID:
11761020
20.

Imaging and estimation of the prognostic features of primary sclerosing cholangitis by ultrasonography and MR cholangiography.

Oikarinen H, Pääkkö E, Suramo I, Päivänsalo M, Tervonen O, Lehtola J, Aukee J.

Acta Radiol. 2001 Jul;42(4):403-8.

PMID:
11442466
21.

Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response.

Ebeling F, Lappalainen M, Vuoristo M, Nuutinen H, Leino R, Karvonen AL, Lehtola J, Julkunen R, Pohjanpelto P, Färkkilä M.

Am J Gastroenterol. 2001 Apr;96(4):1237-42.

PMID:
11316176
22.

Leukocyte interferon-alpha in the treatment of chronic hepatitis C in Finland.

Ebeling F, Lappalainen M, Vuoristo M, Nuutinen H, Leino R, Karvonen AL, Lehtola J, Julkunen R, Pohjanpelto P, Tölö H, Färkkilä M.

Scand J Gastroenterol. 2000 May;35(5):540-5.

PMID:
10868459
23.

Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease.

Heikius B, Niemelä S, Lehtola J, Karttunen TJ.

Am J Gastroenterol. 1999 Apr;94(4):1062-9.

PMID:
10201484
24.

Collagenous colitis and Yersinia enterocolitica infection.

Mäkinen M, Niemelä S, Lehtola J, Karttunen TJ.

Dig Dis Sci. 1998 Jun;43(6):1341-6.

PMID:
9635629
25.

Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis.

Vuoristo M, Färkkilä M, Gylling H, Karvonen AL, Leino R, Lehtola J, Makinen J, Mattila J, Tilvis R, Miettinen TA.

J Hepatol. 1997 Jul;27(1):136-42.

PMID:
9252087
26.

Salivary carbonic anhydrase protects gastroesophageal mucosa from acid injury.

Parkkila S, Parkkila AK, Lehtola J, Reinilä A, Södervik HJ, Rannisto M, Rajaniemi H.

Dig Dis Sci. 1997 May;42(5):1013-9.

PMID:
9149056
27.

Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.

Heikius B, Niemelä S, Lehtola J, Karttunen T, Lähde S.

Scand J Gastroenterol. 1997 Feb;32(2):153-61.

PMID:
9051876
28.

[Celiac disease, treatment guideline].

Collin P, Julkunen R, Lehtola J, Mäki M, Rasmussen M, Reunala T, Savilahti E, Uusitupa M, Vuoristo M.

Duodecim. 1997;113(1):82-7. Finnish. No abstract available.

PMID:
11370063
29.

Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease.

Silvennoinen J, Lamberg-Allardt C, Kärkkäinen M, Niemelä S, Lehtola J.

J Intern Med. 1996 Nov;240(5):285-92.

PMID:
8946811
30.

Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype?

Kervinen K, Södervik H, Mäkelä J, Lehtola J, Niemi M, Kairaluoma MI, Kesäniemi YA.

Gastroenterology. 1996 Jun;110(6):1785-90.

PMID:
8964404
31.

Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis.

Kisand KE, Karvonen AL, Vuoristo M, Färkkilä M, Lehtola J, Inkovaara J, Kisand KV, Miettinen T, Krohn K, Uibo R.

J Mol Med (Berl). 1996 May;74(5):269-72.

PMID:
8773263
32.

Pancreatic duct abnormalities and pancreatic function in patients with chronic inflammatory bowel disease.

Heikius B, Niemelä S, Lehtola J, Karttunen T, Lähde S.

Scand J Gastroenterol. 1996 May;31(5):517-23.

PMID:
8734352
33.

Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease.

Silvennoinen JA, Lehtola JK, Niemelä SE.

Scand J Gastroenterol. 1996 Apr;31(4):367-71.

PMID:
8726305
34.

Gastric cancer: surgical management and prognosis.

Arak A, Lehtola J, Mäkelä J, Tuominen H.

Ann Chir Gynaecol. 1996;85(4):293-8.

PMID:
9014057
35.

A controlled study of bone mineral density in patients with inflammatory bowel disease.

Silvennoinen JA, Karttunen TJ, Niemelä SE, Manelius JJ, Lehtola JK.

Gut. 1995 Jul;37(1):71-6.

36.

Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine.

Miettinen TA, Färkkilä M, Vuoristo M, Karvonen AL, Leino R, Lehtola J, Friman C, Seppälä K, Tuominen J.

Hepatology. 1995 May;21(5):1261-8.

PMID:
7737632
37.

A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.

Vuoristo M, Färkkilä M, Karvonen AL, Leino R, Lehtola J, Mäkinen J, Mattila J, Friman C, Seppälä K, Tuominen J, et al.

Gastroenterology. 1995 May;108(5):1470-8.

PMID:
7729640
38.

[Endoscopy today].

Lehtola J.

Duodecim. 1994;110(20):1833-6. Review. Finnish. No abstract available.

PMID:
7555795
39.

Nerve fiber layer defects with normal visual fields. Do normal optic disc and normal visual field indicate absence of glaucomatous abnormality?

Tuulonen A, Lehtola J, Airaksinen PJ.

Ophthalmology. 1993 May;100(5):587-97; discussion 597-8.

PMID:
8493001
40.
41.

Effect of erythromycin on the oro-caecal transit time in man.

Lehtola J, Jauhonen P, Kesäniemi A, Wikberg R, Gordin A.

Eur J Clin Pharmacol. 1990;39(6):555-8.

PMID:
2095341
42.

Relationship of Campylobacter pylori and duodenogastric reflux.

Niemelä S, Karttunen T, Heikkilä J, Mäentausta O, Lehtola J.

Dig Dis Sci. 1989 Jul;34(7):1021-4.

PMID:
2743841
43.

Pancreatitis in patients with chronic inflammatory bowel disease.

Niemelä S, Lehtola J, Karttunen T, Lähde S.

Hepatogastroenterology. 1989 Jun;36(3):175-7.

PMID:
2753464
44.

Prepyloric erosions: an entity of its own among erosive gastric lesions. A morphologic and dynamic study of gastric mucosa in patients with gastric erosions.

Karvonen AL, Kekki M, Lehtola J, Sipponen P, Ihamäki T.

Scand J Gastroenterol. 1987 Nov;22(9):1095-101.

PMID:
3423734
45.

Treatment of pneumatosis coli with metronidazole. Endoscopic follow-up of one case.

Jauhonen P, Lehtola J, Karttunen T.

Dis Colon Rectum. 1987 Oct;30(10):800-1.

PMID:
3652892
46.

Campylobacter-like organisms in patients with gastric ulcer.

Niemelä S, Karttunen T, Lehtola J.

Scand J Gastroenterol. 1987 May;22(4):487-90.

PMID:
3602929
47.

Campylobacter-like organisms and gastritis: histopathology, bile reflux, and gastric fluid composition.

Karttunen T, Niemelä S, Lehtola J, Heikkilä J, Mäentausta O, Räsänen O.

Scand J Gastroenterol. 1987 May;22(4):478-86.

PMID:
3602928
48.

Characteristics of reflux gastritis.

Niemelä S, Karttunen T, Heikkilä J, Lehtola J.

Scand J Gastroenterol. 1987 Apr;22(3):349-54.

PMID:
3589504
49.
50.

The effect of ethanol with a meal on the mucosa of the stomach and duodenal bulb.

Lehtola J, Pirttiaho H, Niemelä S, Sipponen P, Olsén M, Järvensivu P, Saukko P.

Ann Clin Res. 1987;19(6):391-4.

PMID:
3451692

Supplemental Content

Loading ...
Support Center